FDA Approved Biologics and Pending Applications
Approved Foreign Follow-On Biologics / Biosimilars
Biosimilars Approved In The E.U.
Alymsys® (bevacizumab) (mAbxience) (March-2021)Izamby® / Denbrayce® (denosumab) (mAbxience) (July-2025)